Compare NICE Ltd (NICE) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NICE Ltd vs Recursion Pharmaceuticals Inc — how do they compare? NICE Ltd trades at $94.34 (market cap $5.91B), while Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B). The key difference: NICE Ltd is far larger — about 3.9× Recursion Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| NICE | RXRX | |
|---|---|---|
Market Cap | $5.91B | $1.53B |
Sector | Technology | Health |
52-Week High | $170.37 | $6.79 |
52-Week Low | $83.15 | $2.84 |
Enterprise Value | $5.69B | $946.50M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About NICE Ltd
NICE Ltd. is a global leader in both enterprise software and cloud computing, specializing in customer experience and financial crime prevention solutions. The company's platform utilizes advanced analytics, AI, and automation to help organizations enhance customer interactions, ensure compliance, and combat fraud. NICE serves a diverse client base, including contact centers, financial institutions, and government agencies, by optimizing operations and improving service quality.
Read more on NICE →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
